Submission Details
| 510(k) Number | K222706 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 07, 2022 |
| Decision Date | December 06, 2022 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K222706 is an FDA 510(k) clearance for the iCE-SG2 Subcutaneous Electrode Kit, a Electrode, Depth (Class II — Special Controls, product code GZL), submitted by Ice Neurosystems, Inc. (Washington, US). The FDA issued a Cleared decision on December 6, 2022, 90 days after receiving the submission on September 7, 2022. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1330.
| 510(k) Number | K222706 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 07, 2022 |
| Decision Date | December 06, 2022 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GZL — Electrode, Depth |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1330 |